In patients older than 60 y/o, MGN is associated with malignancy in 20-30% of cases. The lung is most frequently associated in about 26% of the patients, followed by prostate (15%); lymphomas (14%) and others including colorectal, breast, upper GI tract, kidney, and cervix/uterus.
Quick note: This post is to be used for informational purposes only and does not constitute medical or health advice. Each person should consult their own doctor with respect to matters referenced. Arkana Laboratories assumes no liability for actions taken in reliance upon the information contained herein.